Table 2 Baseline characteristics of patients who received mycophenolate
Non-Indigenous Australians (N = 5) | Indigenous Australians (N = 15) | P-value | |
|---|---|---|---|
Age (mean ± SD) | 36.4 ± 6.50 | 36.2 ± 12.37 | 0.97 |
Women, n (%) | 3 (60%) | 13 (87%) | 0.20 |
Diabetes mellitus, n (%) | 0 | 3 (20%) | 0.28 |
Hypertension n (%) | 2 (20%) | 3 (20%) | 0.37 |
Acute rheumatic fever / rheumatic heart disease | 0 | 4 (27%) | 0.20 |
Pre-induction creatinine (μmol/L) | 145.6 (± 131.4) | 142.1 (± 92.25) | 0.947 |
Pre-induction ACR (g/mol) | 135.6 ± 187.7 | 341.1 ± 338.32 | 0.22 |
Pathological Classification | |||
III | 1 (20%) | 6 (40%) | 0.25 |
IV | 3 (60%) | 5 (33%) | |
V | 0 | 2 (13%) | |
III + V | 0 | 2 (13%) | |
IV + V | 1 (20%) | 0 | |